Filing Details

Accession Number:
0001144204-18-009569
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-16 16:42:52
Reporting Period:
2018-02-14
Accepted Time:
2018-02-16 16:42:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1481512 Ra Pharmaceuticals Inc. RARX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1315082 Ra Capital Healthcare Fund Lp C/O Ra Capital Management, Llc
20 Park Plaza, Suite 1200
Boston MA 02116
No No Yes No
1346824 Ra Capital Management, Llc 20 Park Plaza, Suite 1200
Boston MA 02116
Yes No Yes No
1384859 Peter Kolchinsky C/O Ra Capital Management, Llc
20 Park Plaza, Suite 1200
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-14 2,500,000 $6.00 3,851,808 No 4 P Indirect See Note
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Note
Footnotes
  1. These securities include 2,023,134 shares held by RA Capital Healthcare Fund, L.P. (the "Fund") and 476,866 shares held in an account owned by a separately managed account (the "Account").
  2. Represents 3,135,084 shares of Common Stock held by the Fund and 716,724 shares of Common Stock held in the Account.
  3. RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Account. Peter Kolchinsky is the sole manager of the Adviser. The Adviser and Mr. Kolchinsky disclaim beneficial ownership of the reported securities in reliance on Rule 16a-1(a)(1)(v) and (vii) and disclaim any obligation to file reports under Section 16 other than as directors by deputization. The Adviser and Mr. Kolchinsky have no pecuniary interest in the reported securities held in the Account and disclaim: (A) beneficial ownership thereof for purposes of Rule 16a-1(a)(2) and (B) beneficial ownership of securities held by the Fund, for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.